High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice-Reference-Cited by-同舟云学术

High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice

Published:2018-11-13 Issue:6 Volume:68 Page:2380-2404
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ge Xiaodong¹²,Arriazu Elena²,Magdaleno Fernando¹,Antoine Daniel J.³,dela Cruz Rouchelle⁴,Theise Neil⁴⁵,Nieto Natalia¹²⁶

Affiliation:

1. Department of Pathology; University of Illinois at Chicago; Chicago IL

2. Division of Liver Diseases, Department of Medicine; Icahn School of Medicine at Mount Sinai; New York NY

3. MRC Centre for Inflammation Research, Queen’s Medical Research Institute; University of Edinburgh; Edinburgh United Kingdom

4. Division of Digestive Diseases; Mount Sinai Beth Israel Medical Center; New York NY

5. Department of Pathology; New York University Langone Medical Center; New York NY

6. Department of Medicine, Division of Gastroenterology and Hepatology; University of Illinois at Chicago; Chicago IL

Funder

Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and the Center for Innovations in Quality, Effectiveness and Safety

American Association for the Study of Liver Diseases

Asociación Española para el Estudio del Hígado

Wellcome Trust

Medical Research Council

National Institute of Diabetes and Digestive and Kidney Diseases

U.S. Public Health Service

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.30093/fullpdf

Reference41 articles.

1. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury;Arriazu;Gut,2017

2. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD);Ge;J Biol Chem,2014

3. HMG-1 as a late mediator of endotoxin lethality in mice;Wang;Science,1999

4. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis;Huebener;J Clin Invest,2015

5. LPS induces HMGB1 relocation and release by activating the NF-kappaB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264.7;Wu;J Surg Res,2012

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of protein partners for small molecules reshapes the understanding of nonalcoholic steatohepatitis and drug discovery;Life Sciences;2024-11

2. Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges;Frontiers in Pharmacology;2024-08-06

3. RG-I pectin-like polysaccharide from Rosa chinensis inhibits inflammation and fibrosis associated to HMGB1/TLR4/NF-κB signaling pathway to improve non-alcoholic steatohepatitis;Carbohydrate Polymers;2024-08

4. Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis;Acta Biomaterialia;2024-08

5. HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage;Cell Biology and Toxicology;2024-07-15